USFDA approves Merck’s Keytruda plus chemoradiotherapy with FIGO 2014 stage III-IVA cervical cancer
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
He is also inducted as a member of the management council and senior management personnel of the company
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
NEIAFMR to be developed as the national hub for folk medicine
US FDA approval based on NEURO-TTRansform Phase III results
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
Mothers Against Vaping also highlights a recent study of young people at risk of experiencing significant respiratory symptoms after just 30 days of electronic cigarette and other new age gateway products use
Demonstrate significant bleed reduction in hemophilia A and B
Subscribe To Our Newsletter & Stay Updated